血清 Apo 脂蛋白 E,Apo 脂蛋白 E 基因多态,以及帕金森病
Ebtesam M Fahmy1, Amany M Rabah1, Saher E Hashem1
1Department of Neurology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Neurology India
|May 1, 2024
概括
较高的血清阿波利波蛋白E (APOE) 水平和APOE ε2/4基因型与帕金森病 (PD) 有关. APOE ε4与认知能力下降相关,而APOE ε2表明PD患者的疾病持续时间较短.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 脂蛋白E (APOE) 涉及神经退行性过程.
- 了解APOE在帕金森病 (PD) 中的作用对于神经退行研究至关重要.
研究的目的:
- 研究血清APOE水平,APOE基因多态化和帕金森病 (PD) 之间的关系.
- 探索APOE在PD病原和临床表现中的潜在作用.
主要方法:
- 使用ELISA测量了55名PD患者和30名对照患者的血清APOE水平.
- 使用PCR进行了APOE基因多态的基因定型.
- 用UPDRS,Hoehn和Yahr以及Schwab-England等级来评估PD的严重程度.
主要成果:
- 患有PD的患者的血清APOE平均水平明显高于健康对照组.
- 在PD患者中,APOE ε2/4基因型更为普遍.
- APOE ε4等位基因与UPDRS的思维,行为和情绪部分的得分相对较差.
- APOE ε2等位基因与较短的疾病持续时间有关.
- 血清APOE水平升高与UPDRS思维分数和疾病持续时间相关,预测认知症状.
结论:
- APOE ε2/4基因型可能代表帕金森病的易感性因素.
- 在PD的背景下,APOE似乎在调节神经退行起作用.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
7.8K
相关概念视频
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Human Genetics
564
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
564
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
